Year |
Citation |
Score |
2023 |
Deng H, Gao J, Cao B, Qiu Z, Li T, Zhao R, Li H, Wei B. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing. Cellular Oncology (Dordrecht). PMID 37354353 DOI: 10.1007/s13402-023-00835-4 |
0.3 |
|
2023 |
Cao B, Zhao R, Li H, Xu X, Gao J, Chen L, Wei B. Inhibition of androgen receptor enhanced the anticancer effects of everolimus through targeting glucose transporter 12. International Journal of Biological Sciences. 19: 104-119. PMID 36594084 DOI: 10.7150/ijbs.75106 |
0.355 |
|
2022 |
Li H, Cao B, Zhao R, Li T, Xu X, Cui H, Deng H, Gao J, Wei B. circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR-576-3p/Hypoxia Inducible Factor-1 Alpha Axis. Frontiers in Oncology. 12: 817192. PMID 35712504 DOI: 10.3389/fonc.2022.817192 |
0.324 |
|
2021 |
Wang Y, Cao B, Zhao R, Li H, Wei B, Dai G. Knockdown of circBFAR inhibits proliferation and glycolysis in gastric cancer by sponging miR-513a-3p/hexokinase 2 axis. Biochemical and Biophysical Research Communications. 560: 80-86. PMID 33979737 DOI: 10.1016/j.bbrc.2021.04.131 |
0.303 |
|
2016 |
Zhao R, Choi BY, Lee MH, Bode AM, Dong Z. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer. Ebiomedicine. 8: 30-39. PMID 27428416 DOI: 10.1016/j.ebiom.2016.04.017 |
0.701 |
|
2014 |
Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, et al. CSN6 drives carcinogenesis by positively regulating Myc stability. Nature Communications. 5: 5384. PMID 25395170 DOI: 10.1038/ncomms6384 |
0.632 |
|
2014 |
Fuentes-Mattei E, Velazquez-Torres G, Phan L, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Zhao R, Chen J, Gully C, Carlock C, Qi Y, Zhang Y, Wu Y, et al. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer. Journal of the National Cancer Institute. 106. PMID 24957076 DOI: 10.1093/Jnci/Dju158 |
0.646 |
|
2013 |
Zhao R, Yang HY, Shin J, Phan L, Fang L, Che TF, Su CH, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle (Georgetown, Tex.). 12: 935-43. PMID 23421998 DOI: 10.4161/cc.23883 |
0.751 |
|
2012 |
Chen B, Zhao R, Su CH, Linan M, Tseng C, Phan L, Fang L, Yang HY, Yang H, Wang W, Xu X, Jiang N, Cai S, Jin F, Yeung SC, et al. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle (Georgetown, Tex.). 11: 4633-41. PMID 23187808 DOI: 10.4161/cc.22887 |
0.728 |
|
2012 |
Xue Y, Chen J, Choi HH, Phan L, Chou PC, Zhao R, Yang H, Santiago J, Liu M, Yeung GE, Yeung SC, Lee MH. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle (Georgetown, Tex.). 11: 4181-90. PMID 23095642 DOI: 10.4161/cc.22413 |
0.769 |
|
2012 |
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang S, Wang X, Zhang R, Lee MH, Yang H. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle (Georgetown, Tex.). 11: 785-96. PMID 22374676 DOI: 10.4161/cc.11.4.19228 |
0.565 |
|
2011 |
Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle (Georgetown, Tex.). 10: 3057-66. PMID 21876386 DOI: 10.4161/cc.10.18.17320 |
0.673 |
|
2011 |
Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, Zhao R, Phan L, Shaiken T, Chen J, Yeung SC, Lee MH. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene. 30: 4791-801. PMID 21625211 DOI: 10.1038/Onc.2011.192 |
0.737 |
|
2011 |
Zhao R, Fuentes-Mattei E, Velazquez-Torres G, Su CH, Chen J, Lee MH, Yeung SC. Exenatide improves glucocorticoid-induced glucose intolerance in mice. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 4: 61-5. PMID 21448323 DOI: 10.2147/DMSO.S15510 |
0.529 |
|
2011 |
Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. The Journal of Clinical Investigation. 121: 851-65. PMID 21317535 DOI: 10.1172/Jci44111 |
0.727 |
|
2011 |
Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Research. 71: 884-94. PMID 21135113 DOI: 10.1158/0008-5472.CAN-10-2518 |
0.741 |
|
2010 |
Su CH, Zhao R, Velazquez-Torres G, Chen J, Gully C, Yeung SC, Lee MH. Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage. Molecular Cancer. 9: 243. PMID 20843328 DOI: 10.1186/1476-4598-9-243 |
0.673 |
|
2009 |
Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. The American Journal of Pathology. 175: 400-11. PMID 19528349 DOI: 10.2353/ajpath.2009.080972 |
0.676 |
|
2009 |
Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Yeung SC, Lee MH. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene. 28: 2581-92. PMID 19483729 DOI: 10.1038/onc.2009.124 |
0.642 |
|
2008 |
Pan J, Chen B, Su CH, Zhao R, Xu ZX, Sun L, Lee MH, Yeung SC. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biology & Therapy. 7: 1679-84. PMID 18769123 |
0.67 |
|
2006 |
Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Research. 66: 3096-105. PMID 16540659 DOI: 10.1158/0008-5472.Can-05-3620 |
0.752 |
|
2006 |
Yang H, Zhang Y, Zhao R, Wen YY, Fournier K, Wu HB, Yang HY, Diaz J, Laronga C, Lee MH. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt. Oncogene. 25: 4585-94. PMID 16532026 DOI: 10.1038/Sj.Onc.1209481 |
0.756 |
|
2006 |
Yang H, Zhao R, Lee MH. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Molecular Cancer Therapeutics. 5: 253-60. PMID 16505098 DOI: 10.1158/1535-7163.MCT-05-0395 |
0.743 |
|
2006 |
Yang HY, Yang H, Zhao R, Lee MH. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity. Journal of Cellular Biochemistry. 98: 128-38. PMID 16365885 DOI: 10.1002/jcb.20762 |
0.748 |
|
2005 |
Yang H, Zhao R, Yang HY, Lee MH. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene. 24: 1924-35. PMID 15688030 DOI: 10.1038/sj.onc.1208352 |
0.776 |
|
Show low-probability matches. |